Life Science Matters An inside look at the latest legal developments involving medical devices, pharmaceuticals, and more

  • Home
  • About
  • Categories
    • ANDA
    • Class Action
    • Coronavirus
    • Daubert
    • Design Defect
    • FDA
    • IP
    • Labeling
    • Medical Device
    • News
    • Nutritional Supplements
    • Off Label
    • Pharmacy
    • Pharmaceuticals
    • Preemption
    • Recalls
    • Regulatory
    • Sales Representatives
    • Settlements
    • Supplements
    • Verdicts
  • Resources
  • Subscribe
  • Contact Us

This Week’s Life Science Headlines

  • December 26, 2013
  • /
  • FDA Litigation Medical Device News Pharmaceuticals Product Liability Recalls Regulatory
  • /
  • Life Science Matters
        Litigation
  • NECC Fungal Meningitis Settlement May Result in $100M Payment
  • MDL Consolidation for Lipitor Diabetes Lawsuits to be Considered Jan. 30
  • J&J Risperdal Whistleblower Made Millions in Settlement
  • Generic Fosamax Users Must Give More Details in MDL (subscription required)
  • JPML Centralizes Glucosamine False Ad Suits (subscription required)
  • Boehringer May Face More Sanctions in Pradaxa MDL (subscription required)
Regulatory
  • FDA Permits Last-Resort Iclusig Use After Clinical Trial Deaths (subscription required)
  • Proposed Rule – Safety and Effectiveness of Consumer Antiseptics; Topical Antimicrobial
…
Continue reading...
  • abrams royal pharmacy abrams royal pharmacy recall bioequivalence studies with pharmacokinetic endpoints for drugs submitted under an ANDA boehringer ingelheim boehringer sanctions Fosamax fungal meningitis fungal meningitis settlement Gardasil gardasil recall generic Fosamax glucosamine false ad glucosamine false ad suits hospira hospira recall Iclusig J&J Johnson & Johnson last-resort Iclusig Lipitor Lipitor diabetes lawsuits Merck merck recall muscle growth product called mass destruction NECC pradaxa pradaxa MDL recall of Lidocaine HCl risperdal Risperdal whistleblower risperdal whistleblower lawsuit
Goldberg Segalla

Search

Categories

  • Posts
  • Multicounty Litigation Order in New Jersey Provides No Guidance to Practitioners June 23, 2021
  • New Multicounty Litigation Application in New Jersey June 8, 2021
  • Lack of Agreement to Arbitrate Dooms Bid to Compel Arbitration May 26, 2021
  • Mixed Bag in New Jersey Medical Device Preemption Opinion May 12, 2021
  • First Circuit Agrees Pharmacists Provide Services, Not Sell Goods April 27, 2021

About Us

Goldberg Segalla is a national civil litigation firm with more than 20 offices in 10 states spanning major metro markets across the U.S., providing strategic coverage wherever our clients do business. As a firm of experienced litigators and trial attorneys, our capabilities span business and commercial disputes, employment and labor, insurance coverage, product liability, and more. Today, our nearly 400 attorneys are trusted counselors to public and private clients in key sectors and industries including construction and energy, transportation, manufacturing, retail and hospitality, and insurance.

Links

  • Home
  • About
  • Resources
  • Contact Us
Copyright 2022 · Goldberg Segalla